SEC Tracker
Get the app

Cogent Biosciences COGT

Cogent Biosciences: signs a material agreement, sells unregistered shares and 2 other items

Form
8-K
Filed
Period
Importance
Major
Document
8-K
Exhibit 10.1
Material contract
Exhibit 10.2
Material contract
Exhibit 99.1
Press release
  • Signs a material agreement (1.01)
  • Sells unregistered shares (3.02)
  • Amends its charter or bylaws (5.03)
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Cogent Biosciences files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Companies of similar size in SIC 2834 and related industry codes: the same peer list as the financial tables.

  1. uniQure QURE public float $765M, Jun 30, 2025
  2. Phibro Animal Health PAHC public float $764M, Dec 31, 2025
  3. Pacira BioSciences PCRX public float $758M, Jun 30, 2025
  4. Syndax Pharmaceuticals SNDX public float $799M, Jun 30, 2025
  5. Nurix Therapeutics NRIX public float $808M, May 30, 2025